Dr Anna Lysiak M D - 19152 Philadelphia, PA

Business Name: Dr Anna Lysiak M D
Categorized In: Doctors
Address: 8400 Bustleton Avenue # 101, Philadelphia, PA 19152
Phone Number: (215) 725-2291
Contact Person: Anna Lysiak
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2007
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Fabiszewska Ewa MD - Philadelphia, PA 19152
Moskowitz Neal K MD - Philadelphia, PA 19152
Zambrotta Jaime N MD - Philadelphia, PA 19152
Qazi Sajid H DO - Philadelphia, PA 19152
Leyzin Mara MD - Philadelphia, PA 19152
Jeanes Family Practice - Philadelphia, PA 19152
Leddy Cheryl L MD - Philadelphia, PA 19152
Farooq Sabahat MD - Philadelphia, PA 19152
Chelemer Scott B MD - Philadelphia, PA 19152
Berna Gioiamaria MD - Philadelphia, PA 19152
David M Pudles Dr - Philadelphia, PA 19152
Rose Lewis J MD - Philadelphia, PA 19152
Laucius Rose Chapman Ramirez - Philadelphia, PA 19152
Katsev Svetlana MD - Philadelphia, PA 19152
Arnold William MD - Philadelphia, PA 19152
Eye Surgical Medical Assoc - Philadelphia, PA 19152
Shayegan Mustapha MD - Philadelphia, PA 19152
Northeast Cardiology Conslnts - Philadelphia, PA 19152
Sabol Phyllis MD - Philadelphia, PA 19152
Devlin Jeanine G MD - Philadelphia, PA 19152

Dr Anna Lysiak M D provides professional Doctors from its single location at the coordinates 40.069703,-75.050842.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2007, the company can now be visited at 8400 Bustleton Avenue # 101, Philadelphia, Pennsylvania 19152 or contacted through representative Anna Lysiak at (215) 725-2291.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Dr Anna Lysiak M D through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.